Prognostic value of ASXL1 mutations in patients with myelodysplastic syndromes and acute myeloid leukemia: A meta-analysis

被引:4
|
作者
Zhang, Ao [1 ]
Wang, Shuxing [1 ]
Ren, Quanlei [1 ]
Wang, Yizhu [1 ]
Jiang, Zhiping [1 ]
机构
[1] Cent South Univ, Xiangya Hosp, Dept Hematol, 87 Xiang Ya Rd, Changsha 410008, Peoples R China
关键词
acute myeloid leukemia; age; ASXL1; mutations; meta-analysis; myelodysplastic syndromes; CLONAL HEMATOPOIESIS; POOR-PROGNOSIS; OLDER PATIENTS; EXPRESSION; SUBGROUP; AML;
D O I
10.1111/ajco.13897
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Additional sex combs-like 1 (ASXL1) mutations, a hotspot in myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML), have been frequently reported for their potential prognostic value, but the results are controversial. Therefore, a meta-analysis was performed. Databases, including PubMed, Embase, and Cochrane Library, were searched for relevant studies published up to January 13, 2022. STATA v16.0 software was used to calculate the combined hazard ratios (HRs) and their 95% confidence intervals (CIs) for overall survival (OS) and AML transformation. Subgroup analysis was used to explore the effects of the grouping factors on heterogeneity.Ten studies on ASXL1 mutations and the prognosis of MDS were selected. Our results indicate that ASXL1 mutations have an adverse prognostic impact on OS (HR = 1.68,95%CI:1.45-1.94, p < .0001) and AML transformation (HR = 2.20,95% CI:1.68-2.87, p < .0001). The results for different age groups were not significantly different (HR = 1.87,95% CI: 1.31-2.67; HR = 1.62,95% CI:1.35-2.07). Ten studies covering 5816 patients with AML were included. The pooled HR for OS was 1.37 (95% CI:1.20-1.56, p < .0001). ASXL1 mutations were especially associated with a poorer OS in the subgroup aged >= 60 years (HR = 2.86, 95% CI:1.34-6.08, p = .006); when considering cytogenetically normal AML (CN-AML), the HR was 1.78(95% CI:1.27-2.49, p = .001). This meta-analysis indicates an independent, adverse prognostic impact of ASXL1 mutations in patients with MDS and AML, which also applies to patients with CN-AML. Age was a risk factor for patients with AML and ASXL1 mutations but not for patients with MDS.
引用
收藏
页码:E183 / E194
页数:12
相关论文
共 50 条
  • [1] Prognostic value of ASXL1 mutations in acute myeloid leukemia: A meta-analysis
    Lipilkin, P. V.
    Kulaeva, E. D.
    Mashkina, E. V.
    LEUKEMIA RESEARCH, 2022, 120
  • [2] Prognostic significance of ASXL1 mutations in myelodysplastic syndromes and chronic myelomonocytic leukemia: A meta-analysis
    Lin, Yun
    Zheng, Yi
    Wang, Ze-Chuan
    Wang, Shao-Yuan
    HEMATOLOGY, 2016, 21 (08) : 454 - 461
  • [3] Prognostic significance of ASXL1 mutations in acute myeloid leukemia: A systematic review and meta-analysis
    Sheikhi, Maryam
    Rostami, Mehrdad
    Ferns, Gordon
    Ayatollahi, Hossein
    Siyadat, Payam
    Ayatollahi, Yasamin
    Khoshnegah, Zahra
    CASPIAN JOURNAL OF INTERNAL MEDICINE, 2024, 15 (02) : 202 - 214
  • [4] Prognostic Significance of ASXL1 Mutations in Patients With Myelodysplastic Syndromes
    Thol, Felicitas
    Friesen, Inna
    Damm, Frederik
    Yun, Haiyang
    Weissinger, Eva M.
    Krauter, Juergen
    Wagner, Katharina
    Chaturvedi, Anuhar
    Sharma, Amit
    Wichmann, Martin
    Goehring, Gudrun
    Schumann, Christiane
    Bug, Gesine
    Ottmann, Oliver
    Hofmann, Wolf-Karsten
    Schlegelberger, Brigitte
    Heuser, Michael
    Ganser, Arnold
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (18) : 2499 - 2506
  • [5] Acquired mutations in ASXL1 in acute myeloid leukemia: prevalence and prognostic value
    Pratcorona, Marta
    Abbas, Saman
    Sanders, Mathijs A.
    Koenders, Jasper E.
    Kavelaars, Francois G.
    Erpelinck-Verschueren, Claudia A. J.
    Zeilemakers, Annelieke
    Lowenberg, Bob
    Valk, Peter J. M.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2012, 97 (03): : 388 - 392
  • [6] PROGNOSTIC SIGNIFICANT OF ASXL1 MUTATIONS IN MYELODYSPLASTIC SYNDROMES
    Wang, S. Y.
    Lin, Y.
    Zheng, Y.
    Wang, Z. C.
    HAEMATOLOGICA, 2016, 101 : 501 - 501
  • [7] Clinical characteristics and prognostic study of adult acute myeloid leukemia patients with ASXL1 mutations
    Lin, Yun
    Wang, Yaping
    Zheng, Yi
    Wang, Zechuan
    Wang, Yanni
    Wang, Shaoyuan
    HEMATOLOGY, 2020, 25 (01) : 446 - 456
  • [8] PROGNOSTIC VALUE OF MUTATIONS IN ASXL1 IN CHRONIC MYELOMONOCYTIC LEUKEMIA
    Almorox Rebeca, Bailen
    Gonzalez Julia, Suarez
    Carolina, Martinez-Laperche
    Noemi, Fernandez-Escalada
    Maria, Chicano-Lavilla
    Diego, Carbonell
    Patricia, Font
    Santiago, Osorio
    Jose Lui, Diez-Martin
    Ismael, Buno
    HAEMATOLOGICA, 2016, 101 : 153 - 154
  • [9] Prognosis and risk factors for ASXL1 mutations in patients with newly diagnosed acute myeloid leukemia and myelodysplastic syndrome
    Yang, Liqing
    Wei, Xiaoyu
    Gong, Yuping
    CANCER MEDICINE, 2024, 13 (01):
  • [10] Frequent mutation of the polycomb-associated gene ASXL1 in the myelodysplastic syndromes and in acute myeloid leukemia
    J Boultwood
    J Perry
    A Pellagatti
    M Fernandez-Mercado
    C Fernandez-Santamaria
    M J Calasanz
    M J Larrayoz
    M Garcia-Delgado
    A Giagounidis
    L Malcovati
    M G Della Porta
    M Jädersten
    S Killick
    E Hellström-Lindberg
    M Cazzola
    J S Wainscoat
    Leukemia, 2010, 24 : 1062 - 1065